ORAL-CONTRACEPTIVES AND CONGENITAL LIMB-REDUCTION DEFECTS

被引：191

作者：

JANERICH, DT ^{[1
]}

PIPER, JM ^{[1
]}

GLEBATIS, DM ^{[1
]}

机构：

[1] NEW YORK STATE DEPT HLTH, BIRTH DEFECTS INST, DEPT EPIDEMIOL & POPULATION GENET, 84 HOLLAND AVE, ALBANY, NY 12208 USA

来源：

关键词：

D O I：

10.1056/NEJM197410032911403

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：697 / 700

页数：4

共 8 条

[1] BALCI S, 1973, LANCET, V2, P1098
[2] FETAL MASCULINIZING ACTION OF CERTAIN ORAL PROGESTINS
GRUMBACH, MM
DUCHARME, JR
MOLOSHOK, RE
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1959, 19 (11) : 1369 - 1380
[3] KAUFMAN RL, 1973, LANCET, V1, P1395
[4] LEVY EP, 1973, LANCET, V1, P611
[5] CONGENITAL-MALFORMATION SURVEILLANCE SYSTEM BASED ON VITAL RECORDS
MILHAM, S
[J]. PUBLIC HEALTH REPORTS, 1963, 78 (05) : 448 - 452
[6] MILHAM S, 1971, MONITORING BIRTH DEF, P137
[7] NORA JJ, 1973, LANCET, V1, P941
[8] MASCULINIZATION OF FEMALE FETUS DUE TO USE OF ORALLY GIVEN PROGESTINS
WILKINS, L
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 172 (10): : 1028 - 1032